3102 related articles for article (PubMed ID: 15963817)
1. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
2. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
[TBL] [Abstract][Full Text] [Related]
3. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
4. Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall.
Yao X; Teruya-Feldstein J; Raffeld M; Sorbara L; Jaffe ES
Mod Pathol; 2001 Feb; 14(2):105-10. PubMed ID: 11235901
[TBL] [Abstract][Full Text] [Related]
5. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
Griesser DH
Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric detection of CD79a expression in T-cell acute lymphoblastic leukemias.
Lai R; Juco J; Lee SF; Nahirniak S; Etches WS
Am J Clin Pathol; 2000 Jun; 113(6):823-30. PubMed ID: 10874883
[TBL] [Abstract][Full Text] [Related]
7. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
Nichols GE; Normansell DE; Williams ME
Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma.
Rütgen BC; Hammer SE; Gerner W; Christian M; de Arespacochaga AG; Willmann M; Kleiter M; Schwendenwein I; Saalmüller A
Leuk Res; 2010 Jul; 34(7):932-8. PubMed ID: 20153049
[TBL] [Abstract][Full Text] [Related]
9. GeneScanning analysis of Ig/TCR gene rearrangements to detect clonality in canine lymphomas.
Gentilini F; Calzolari C; Turba ME; Bettini G; Famigli-Bergamini P
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):47-56. PubMed ID: 18963006
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
[TBL] [Abstract][Full Text] [Related]
12. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic classification of canine malignant lymphoma on formalin-mixed paraffin wax-embedded tissue by means of CD3 and CD79a cell markers.
Milner RJ; Pearson J; Nesbit JW; Close P
Onderstepoort J Vet Res; 1996 Dec; 63(4):309-13. PubMed ID: 9173362
[TBL] [Abstract][Full Text] [Related]
14. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
15. Gene rearrangements in T-cell lymphoblastic lymphoma.
Pilozzi E; Müller-Hermelink HK; Falini B; de Wolf-Peeters C; Fidler C; Gatter K; Wainscoat J
J Pathol; 1999 Jul; 188(3):267-70. PubMed ID: 10419594
[TBL] [Abstract][Full Text] [Related]
16. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
17. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
18. Marker discrepancy as a diagnostic criterion for lymphoid neoplasms.
Sun T; Ngu M; Henshall J; Cuomo J; Eisenberg A; Benn P; Allen SL
Diagn Clin Immunol; 1988; 5(6):393-9. PubMed ID: 3265362
[TBL] [Abstract][Full Text] [Related]
19. Use of flow cytometric immunophenotyping to refine the cytological diagnosis of canine lymphoma.
Comazzi S; Gelain ME
Vet J; 2011 May; 188(2):149-55. PubMed ID: 20413335
[TBL] [Abstract][Full Text] [Related]
20. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]